Lisata Therapeutics LSTA
NASDAQ LSTA
$1.54 +0.10 (+7.32%)
As of: Oct 1, 2026 · 2:14 PM EDT

Lisata Therapeutics (LSTA) Preferred Stock Liabilities (2010 - 2012)

Updated

Lisata Therapeutics (LSTA) reported Preferred Stock Liabilities of $2.72 million for Q3 2012, down 50.3% from $5.48 million a year earlier and down 23.9% from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Preferred Stock Liabilities (2010 - 2012) Analysis & Trends

At the end of FY2011, Lisata Therapeutics posted Preferred Stock Liabilities of $4.81 million, down 26.3% from FY2010.

  • By year, Preferred Stock Liabilities came in at $6.53 million in FY2010.
  • Per Business Quant data, the three quarters before Q3 2012 came in at $3.57 million (Q2 2012), $4.18 million (Q1 2012) and $4.81 million (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lisata Therapeutics 13.13 Mn 12.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 2.72 Mn
Jun 30, 2012 3.57 Mn
Mar 31, 2012 4.18 Mn
Dec 31, 2011 4.81 Mn
Sep 30, 2011 5.48 Mn
Jun 30, 2011 5.90 Mn
Dec 31, 2010 6.53 Mn
API Access

Lisata Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=LSTA&period=max&api_key=YOUR_API_KEY